ArticleEnvironment & health (Washington, D.C.)2026
Occurrence Patterns of Bisphenol Analogues in Human Blood, Subcutaneous Fat, and Visceral Fat.
Article in Environment & health (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bisphenol M Impairs Ovarian Function through Disrupting Estrogen Synthesis in Female Mice: A Comparative Study with Bisphenol A.Environment & health (Washington, D.C.) · 2026Article
- Emerging evidence for skeletal muscle as a target of BPA exposure.BMC endocrine disorders · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bisphenol analogues (BPs) are well-established endocrine-disrupting chemicals (EDCs). While they are generally not classified as persistent organic pollutants due to their relatively rapid metabolism and urinary excretion, a fraction can accumulate in tissues, including the adipose. This bioaccumulation raises concerns about the potential for prolonged endocrine disruption and chronic toxicity. This study investigated the distribution and accumulation of nine BPs in human blood, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT). By comparing the detection rates and concentrations of BPs in paired blood and adipose samples, we found that certain BPs (particularly BPF, BPE, and BPA-G) exhibit preferential accumulation in adipose tissues. The accumulation propensity was slightly higher in SAT than in VAT. Correlation analysis revealed that the sources of the same BP in VAT and SAT were highly consistent, whereas most BPs in adipose tissues had significantly different sources compared with those in blood. Further analysis suggested that age and obesity might be key factors influencing the differential accumulation of BPs in adipose tissues. Since accumulated BPs can be slowly or substantially released during lipolysis, our findings highlight that the adipose tissue reservoir of BPs may play an important role in their long-term toxic effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.